Home › Funds › GW HENSSLER & ASSOCIATES LTD › NVS
GW HENSSLER & ASSOCIATES LTD position in NVS
NOVARTIS AG · Health Care
GW HENSSLER & ASSOCIATES LTD reported holding 123,971 shares of NVS (NOVARTIS AG) in its Q2 2026 13F filing — a position valued at US$19.4M, representing 0.86% of its reported portfolio and ranking #43 among its reported holdings. GW HENSSLER & ASSOCIATES LTD has disclosed NVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How GW HENSSLER & ASSOCIATES LTD's NVS position evolved
GW HENSSLER & ASSOCIATES LTD first disclosed a stake in NVS in Q3 2023 at 236,835 shares (US$24.1M). The position peaked in Q3 2024 at 250,878 shares, worth US$28.9M. Across 12 filings, GW HENSSLER & ASSOCIATES LTD increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 123,971 shares valued at US$19.4M — a reduction of -1,541 shares quarter over quarter.. Notable position changes include a 45% trim in Q1 2025 (shares rose 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 236.84K | $24.12M | New |
| Q4 2023 | 247.23K | $24.96M | Add |
| Q1 2024 | 248.63K | $24.05M | Add |
| Q2 2024 | 249.22K | $26.53M | Hold |
| Q3 2024 | 250.88K | $28.86M | Add |
| Q4 2024 | 246.80K | $28.39M | Reduce |
| Q1 2025 | 136.42K | $15.21M | Reduce |
| Q2 2025 | 135.41K | $16.39M | Reduce |
| Q3 2025 | 133.47K | $17.12M | Reduce |
| Q4 2025 | 129.06K | $17.79M | Reduce |
| Q1 2026 | 125.51K | $19.17M | Reduce |
| Q2 2026 | 123.97K | $19.43M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVS and 13F data
NVS (NOVARTIS AG) is a Health Care company. 24 other funds we track also report a position in NVS — the largest reported positions include Fisher Asset Management, LLC (US$2.43B), PRIMECAP MANAGEMENT CO/CA/ (US$1.03B), LOOMIS SAYLES & CO L P (US$821.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVS
- Fisher Asset Management, LLC 15.52M sh · $2.43B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 6.59M sh · $1.03B · Q2 2026
- LOOMIS SAYLES & CO L P 5.24M sh · $821.10M · Q2 2026
- NATIXIS ADVISORS, LLC 2.39M sh · $374.02M · Q2 2026
- GQG Partners LLC 2.15M sh · $337.13M · Q2 2026
- Cullen Capital Management, LLC 2.03M sh · $318.62M · Q2 2026
- WCM INVESTMENT MANAGEMENT, LLC 1.90M sh · $300.11M · Q2 2026
More on GW HENSSLER & ASSOCIATES LTD
FAQ
How long has GW HENSSLER & ASSOCIATES LTD held NVS?
GW HENSSLER & ASSOCIATES LTD has disclosed NVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is GW HENSSLER & ASSOCIATES LTD's current position in NVS?
As of Q2 2026, GW HENSSLER & ASSOCIATES LTD holds 123.97K shares of NVS (NOVARTIS AG), valued at $19.43M, representing 0.86% of its reported portfolio and ranking #43.
Has GW HENSSLER & ASSOCIATES LTD been buying or selling NVS?
In the latest 13F filing (Q2 2026), GW HENSSLER & ASSOCIATES LTD reduced its position in NVS. The position peaked in Q3 2024 at 250.88K shares.
Which other funds hold NVS?
Other major institutional holders of NVS include Fisher Asset Management, LLC, PRIMECAP MANAGEMENT CO/CA/, LOOMIS SAYLES & CO L P, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.